Infliximab-abda Intravenous and Liver disease
Result of checking the interaction of drug Infliximab-abda Intravenous and disease Liver disease for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Severe hepatic reactions, including acute liver failure, jaundice, hepatitis and cholestasis, have been reported with the use of infliximab. Infliximab should be discontinued if jaundice and/or marked liver enzyme elevations (e.g., greater than or equal to 5 times the upper limit of normal) develop and a thorough investigation of the abnormality should be undertaken.
Generic Name: infliximab
Brand Name: Inflectra, Remicade, Renflexis
Synonyms: Infliximab, InFLIXimab
Infliximab-abda Intravenous - choroba wątroby 
Infliximab-abda Intravenous - doença hepática 
Infliximab-abda Intravenous - penyakit hati 
Infliximab-abda Intravenous - penyakit hati 
Infliximab-abda Intravenous - malattia del fegato 
Infliximab-abda Intravenous - maladie du foie 
Infliximab-abda Intravenous - Leber erkrankung 
Infliximab-abda Intravenous - enfermedad del higado 
Infliximab-abda Intravenous - заболевание печени 
Infliximab-abda Intravenous - karaciğer hastalığı 
Infliximab-abda Intravenous - مرض الكبد 
Infliximab-abda Intravenous - 肝病